UNLABELLED: Ten out of 37 patients with advanced malignant diseases were found to have extractable amounts of DNA in their plasma whereas no DNA could be detected in 50 normal controls. After its purification from the original nucleoprotein complex, DNA plasma levels ranging from 0.15 to 12 micrograms/ml were measured, the lowest concentration detectable with our method being 0.1 microgram/ml. Knowing from recovery experiments performed with 32P-DNA that the loss of DNA during the extraction procedure is about 65%, the real concentration of DNA in the plasma corresponds to about 3 times the given figures. The purified DNA was shown to be double-stranded and composed of fractions ranging from 21 kb to less than 0.5 kb, as determined by agarose gel electrophoresis. All these fractions hybridized with a 32P-labelled human DNA probe indicating the human origin of the bulk of the circulating DNA. IN CONCLUSION: the finding of extractable amounts of DNA in the plasma of 27% of the investigated cancer patients, and its absence from the controls, suggests some correlation with malignancy.
UNLABELLED: Ten out of 37 patients with advanced malignant diseases were found to have extractable amounts of DNA in their plasma whereas no DNA could be detected in 50 normal controls. After its purification from the original nucleoprotein complex, DNA plasma levels ranging from 0.15 to 12 micrograms/ml were measured, the lowest concentration detectable with our method being 0.1 microgram/ml. Knowing from recovery experiments performed with 32P-DNA that the loss of DNA during the extraction procedure is about 65%, the real concentration of DNA in the plasma corresponds to about 3 times the given figures. The purified DNA was shown to be double-stranded and composed of fractions ranging from 21 kb to less than 0.5 kb, as determined by agarose gel electrophoresis. All these fractions hybridized with a 32P-labelled human DNA probe indicating the human origin of the bulk of the circulating DNA. IN CONCLUSION: the finding of extractable amounts of DNA in the plasma of 27% of the investigated cancerpatients, and its absence from the controls, suggests some correlation with malignancy.
Authors: Avery Sonnenberg; Jennifer Y Marciniak; James McCanna; Rajaram Krishnan; Laura Rassenti; Thomas J Kipps; Michael J Heller Journal: Electrophoresis Date: 2013-04 Impact factor: 3.535
Authors: Re-I Chin; Kevin Chen; Abul Usmani; Chanelle Chua; Peter K Harris; Michael S Binkley; Tej D Azad; Jonathan C Dudley; Aadel A Chaudhuri Journal: Mol Diagn Ther Date: 2019-06 Impact factor: 4.074
Authors: Hengshan Zhang; Steven B Zhang; Weimin Sun; Shanmin Yang; Mei Zhang; Wei Wang; Chaomei Liu; Kunzhong Zhang; Steven Swarts; Bruce M Fenton; Peter Keng; David Maguire; Paul Okunieff; Lurong Zhang Journal: Int J Radiat Oncol Biol Phys Date: 2009-08-01 Impact factor: 7.038
Authors: Alain R Thierry; Florent Mouliere; Celine Gongora; Jeremy Ollier; Bruno Robert; Marc Ychou; Maguy Del Rio; Franck Molina Journal: Nucleic Acids Res Date: 2010-05-21 Impact factor: 16.971